scholarly journals 52: Cystic fibrosis newborn screening: Barriers and facilitators identified from 10 years of universal screening in the United States

2021 ◽  
Vol 20 ◽  
pp. S26
Author(s):  
M. Sontag ◽  
S. McKasson ◽  
J. Miller ◽  
P. Farrell ◽  
C. Ren ◽  
...  
2020 ◽  
Vol 19 ◽  
pp. S58-S59
Author(s):  
S.L. Martiniano ◽  
A. Elbert ◽  
P.M. Farrell ◽  
N. Fisher ◽  
C.L. Ren ◽  
...  

2018 ◽  
Vol 57 (2) ◽  
Author(s):  
Ravikiran Vasireddy ◽  
Sruthi Vasireddy ◽  
Barbara A. Brown-Elliott ◽  
Alexander L. Greninger ◽  
Rebecca M. Davidson ◽  
...  

ABSTRACTWe characterize three respiratory isolates of the recently described speciesMycobacterium talmoniaerecovered in Texas, Louisiana, and Massachusetts, including the first case of disease in a patient with underlying cystic fibrosis. The three isolates had a 100% match toM. talmoniaeNE-TNMC-100812Tby complete 16S rRNA,rpoBregion V, andhsp65 gene sequencing. Core genomic comparisons between one isolate and the type strain revealed an average nucleotide identity of 99.8%. The isolates were susceptible to clarithromycin, amikacin, and rifabutin, while resistance was observed for tetracyclines, ciprofloxacin, and linezolid.M. talmoniaeshould be added to the list of potential pulmonary pathogens, including in the setting of cystic fibrosis.


Sign in / Sign up

Export Citation Format

Share Document